Your browser doesn't support javascript.
loading
Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison.
Bhak, Rachel H; Mody-Patel, Nikita; Baver, Scott B; Kunzweiler, Colin; Yee, Christopher W; Sundaresan, Sanjana; Swartz, Natalia; Duh, Mei Sheng; Krishnan, Sangeeta; Sarda, Sujata P.
Afiliação
  • Bhak RH; Analysis Group, Inc, Boston, MA, USA.
  • Mody-Patel N; Apellis Pharmaceuticals, Inc, Waltham, MA, USA.
  • Baver SB; Apellis Pharmaceuticals, Inc, Waltham, MA, USA.
  • Kunzweiler C; Analysis Group, Inc, Boston, MA, USA.
  • Yee CW; Analysis Group, Inc, Boston, MA, USA.
  • Sundaresan S; Analysis Group, Inc, Boston, MA, USA.
  • Swartz N; Analysis Group, Inc, Boston, MA, USA.
  • Duh MS; Analysis Group, Inc, Boston, MA, USA.
  • Krishnan S; Apellis Pharmaceuticals, Inc, Waltham, MA, USA.
  • Sarda SP; Apellis Pharmaceuticals, Inc, Waltham, MA, USA.
Curr Med Res Opin ; 37(11): 1913-1923, 2021 11.
Article em En | MEDLINE | ID: mdl-34445916
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemoglobinúria Paroxística Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemoglobinúria Paroxística Idioma: En Ano de publicação: 2021 Tipo de documento: Article